<DOC>
	<DOCNO>NCT01534715</DOCNO>
	<brief_summary>The purpose study test safety tolerability IMGN529 patient relapse refractory non-Hodgkin 's lymphoma ( NHL ) Chronic Lymphocytic Leukemia ( CLL ) .</brief_summary>
	<brief_title>IMGN529 Treating Patients With Relapsed Refractory Non-Hodgkin 's Lymphoma Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Relapsed refractory NHL include tumor type : Follicular lymphoma ( FL ) , marginal zone lymphoma ( MZL ) /mucosaassociated lymphoid tissue ( MALT ) , diffuse large Bcell lymphoma ( DLBCL ) , mantle cell lymphoma ( MCL ) , chronic lymphocytic leukemia ( CLL ) . Adequate organ function ECOG â‰¤ 2 Recovered stabilize prior treatment . Allogeneic stem cell transplantation Pregnant lactating female Known central nervous system , meningeal epidural disease include brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>